IL15 and neoplasm: While IL-15 has also shown promise as a monotherapy in a variety of tumor models by facilitating induction of CD8+ T cells and NK cells, its antitumor effect is synergistically enhanced when administered in combination with other cytokines, including IL-12 [16,17].